HealthStream, Inc. (HSTM) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates strong subscription revenue growth, particularly in key products like CredentialStream and ShiftWizard, alongside optimistic revenue guidance. Despite some concerns over professional services and legacy revenue, the company's strategic focus on AI and product integration suggests future growth potential. The Q&A section highlighted positive analyst sentiment, despite some evasive management responses. The stock is likely to see a positive movement, potentially boosted by the company's strong financial metrics and optimistic guidance.
Key Financial Performance
Full Year 2025 Revenue Revenues up 4.3% year-over-year. Growth attributed to strong performance in subscription products and new acquisitions.
Full Year 2025 Adjusted EBITDA Adjusted EBITDA up 7.5% year-over-year. Increase driven by operational efficiencies and revenue growth.
Fourth Quarter 2025 Revenue Revenues up 7.4% year-over-year. Growth supported by strong subscription product performance and acquisitions.
Fourth Quarter 2025 Adjusted EBITDA Adjusted EBITDA up 16.4% year-over-year. Growth attributed to increased subscription revenues and operational improvements.
Fourth Quarter 2025 Operating Income Operating income down 48.8% year-over-year. Decline due to non-cash compensation expense from CEO stock grant and acquisition-related costs.
Fourth Quarter 2025 Net Income Net income down 48.1% year-over-year. Decline influenced by non-cash compensation expense and acquisition-related costs.
Fourth Quarter 2025 Non-GAAP Operating Income Non-GAAP operating income up 31.7% year-over-year. Increase due to adjustments excluding CEO stock grant impact.
Fourth Quarter 2025 Non-GAAP Net Income Non-GAAP net income up 9.5% year-over-year. Growth driven by adjustments excluding CEO stock grant impact.
Fourth Quarter 2025 Subscription Revenue Subscription revenues up 8.2% year-over-year. Growth driven by CredentialStream (21%), ShiftWizard (31%), and Competency Suite (27%).
Fourth Quarter 2025 Professional Services Revenue Professional services revenues down 11.6% year-over-year. Decline attributed to reduced demand for legacy services.
CredentialStream Revenue (Q4 2025) Revenue up 21% year-over-year. Growth driven by conversions from legacy products and new customer acquisitions.
ShiftWizard Revenue (Q4 2025) Revenue up 31% year-over-year. Growth attributed to health care-specific advantages and customer demand.
Competency Suite Revenue (Q4 2025) Revenue up 27% year-over-year. Growth supported by strong customer adoption and bundled sales.
Free Cash Flow (Full Year 2025) Free cash flow up 5.5% year-over-year. Increase driven by higher cash flows from operations.
Capital Expenditures (Full Year 2025) Capital expenditures up 14.3% year-over-year. Increase due to investments in product development and infrastructure.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
NurseGrid career network: Adding about 2,000 new nurses a week, now has over 670,000 monthly active users, representing 1 out of 5 nurses in the U.S.
myCNAjobs: Acquired MissionCare Collective, introducing myCNAjobs as a new career network to recruit and retain home health aides, home care providers, and CNAs.
Competency Suite: Key sales to top healthcare organizations like Intermountain Health, Northside Hospital, and Dartmouth Health.
Healthcare workforce expansion: Healthcare accounted for 82,000 of the 130,000 new jobs in January 2026. Nursing workforce projected to grow significantly.
CredentialStream and ShiftWizard: CredentialStream revenues grew 21% in Q4, and ShiftWizard revenues grew 31% in Q4, reflecting strong market demand.
Financial performance: Revenues up 7.4% in Q4 and adjusted EBITDA up 16.4%. Full-year revenue reached $304.1 million, with adjusted EBITDA of $71.8 million.
Acquisitions: Completed acquisitions of Virsys12 and MissionCare Collective, deploying $35.1 million for acquisitions in Q4.
Shareholder returns: Authorized $10 million share repurchase program and increased quarterly cash dividend by 12.9%.
AI and data strategy: Positioned as a system of record for healthcare organizations, leveraging proprietary data and AI to enhance workforce management.
Platform strategy: hStream Platform enables interoperability and ecosystem development, connecting SaaS applications and career networks.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
AI Impact on Workforce: Concerns about the potential for AI to disrupt the workforce, though HealthStream believes its healthcare focus mitigates this risk. However, the reliance on AI for efficiencies and insights could pose challenges if not managed effectively.
Data Security and Reliability: The company emphasizes its role as a system of record, but this also means it must maintain high standards of data security and reliability. Any breach or failure could significantly impact customer trust and operations.
Acquisition Integration: Recent acquisitions (Virsys12 and MissionCare Collective) need to be effectively integrated to realize their full value. Poor integration could lead to operational inefficiencies and financial underperformance.
Market Competition: The company faces competitive pressures, particularly in credentialing and scheduling solutions. Failure to differentiate its offerings could impact market share.
Economic Conditions: Economic uncertainties could affect customer budgets and spending on HealthStream's solutions, potentially impacting revenue growth.
Regulatory Compliance: As a healthcare technology company, HealthStream must navigate complex regulatory requirements. Non-compliance could result in legal and financial repercussions.
Customer Retention and Conversion: The transition of customers from legacy products to new solutions like CredentialStream and ShiftWizard is critical. Failure to retain customers during this transition could impact revenue.
Platform and Ecosystem Development: The success of the hStream platform and its ecosystem is crucial. Any delays or failures in its development could hinder the company's strategic objectives.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations for 2026: HealthStream anticipates revenue between $323 million and $330 million, representing a growth rate range of 6.2% to 8.5%. The first quarter revenue growth rate is estimated to be approximately 8%, with higher growth rates expected in the first half of the year.
Net Income and Adjusted EBITDA Projections for 2026: Net income is projected to range between $20.4 million and $22.8 million, while adjusted EBITDA is expected to range between $73 million and $77 million.
Capital Expenditures for 2026: Capital expenditures are expected to range between $31 million and $34 million.
Market Trends and Workforce Growth: The healthcare workforce, particularly nursing, is projected to grow significantly in the coming years. HealthStream expects this trend to expand opportunities for growth in its user base.
AI Integration and Data Utilization: HealthStream plans to leverage AI to enhance its systems of record and proprietary data, which are expected to drive efficiencies and actionable insights for healthcare organizations.
Career Networks Expansion: The company aims to expand its career networks, including NurseGrid and myCNAjobs, to connect healthcare professionals with employers, leveraging proprietary data to improve workforce management.
Platform Strategy: HealthStream will continue to invest in its hStream Platform to enhance interoperability and create an ecosystem that integrates its SaaS applications and career networks.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly cash dividend: The Board of Directors declared a quarterly cash dividend of $0.035 per share to be paid on March 20 to holders of record on March 9. This represents a 12.9% increase over the previous quarterly cash dividend.
Share repurchase program: The Board of Directors authorized a $10 million share repurchase program in November, with $5 million of the repurchases made in the fourth quarter and the remainder purchased in January. Additionally, a $25 million share repurchase program was completed in the third quarter of 2025.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the margins for MissionCare, and is there an opportunity to align them with the corporate average?
A:The company does not report margins on a per-product line basis. However, blended gross margins have seen some compression due to increased costs in hosting services and application suites. Management believes that software businesses, including MissionCare, have the potential to improve blended gross margins over time.
Q:Are there M&A opportunities with platforms being integrated into HealthStream, and does AI enhance the stickiness of HealthStream's platform?
A:Management highlighted the importance of being a system of record, which differentiates HealthStream from point solutions. Customers are increasingly using APIs to integrate third-party data into HealthStream's platform, showcasing its strength. While AI is a fundamental component of the platform, management did not directly address specific M&A opportunities.
Q:What interoperability features of myClinicalExchange resonate most with customers?
A:myClinicalExchange has grown significantly since acquisition, tripling its revenue. An example of interoperability is a widget that connects clinical students doing rotations with hospital managers, improving recruitment opportunities. This feature allows hospitals to engage with students during rotations, enhancing hiring prospects.
Q:How much legacy revenue remains, and when will the company consider sunsetting legacy products?
A:Legacy revenues account for about 10% of total revenues, approximately $30 million. These revenues are from applications no longer sold but still supported. Management has not set a timeline for sunsetting these products but will evaluate this as the legacy revenue base decreases.
Q:Does AI change the company's capital deployment strategy?
A:Yes, capital is being allocated to AI-related initiatives, including data management, classification, and rights management. The company is focused on organizing data and leveraging AI to enhance product development and competitive advantage.
Q:Are there any hesitations in the market due to AI, and how is the sales cadence?
A:The fourth quarter was strong, with significant wins in various product areas. While there is market discussion about AI, HealthStream focuses on providing value through its platform and addressing customer needs, such as workforce onboarding and recruitment.
Q:What is the contribution of Virsys12 and MissionCare acquisitions to revenue?
A:The fourth-quarter impact of both acquisitions combined was $1.6 million, and the full-year guidance includes $13 million from these acquisitions.
Q:How is the company integrating AI into its offerings?
A:Every product has an AI roadmap, and developers are using AI tools to enhance workflows and applications. Specific examples were not provided, but AI is a core element of the hStream platform.
Q:Are health systems creating separate AI budgets or focusing on business improvements?
A:Health systems are focused on consolidating point solutions and addressing business challenges, such as workforce recruitment and onboarding. While AI is a topic of discussion, the emphasis remains on solving fundamental business problems.
Q:How are price escalators performing, and are they meeting expectations?
A:Price escalators are now included in all contracts and are performing as expected. They provide a smoothing function for budget planning and are gradually impacting financial results as contracts renew.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing specific M&A opportunities related to platforms being integrated into HealthStream. Additionally, while discussing AI integration, specific examples of how AI is being used in products were not provided, and the response remained generic.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI health
HealthStream system
MissionCare Collective
Virsys
ad libbing
adjustment
care organization
care workforce
career network
category
change
compensation expense
consideration
core element
decade
ecosystem
employer
expense CEO
grant
hStream Platform
health care
increase cash
industry partner
job
learning record
million
nurse CNAs
nursing workforce
position
projection
record behalf
script
stock
strength
system record
trend
user base
HSTM Transcript
HealthStream, Inc. (HSTM) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call summary indicates strong subscription revenue growth, particularly in key products like CredentialStream and ShiftWizard, alongside optimistic revenue guidance. Despite some concerns over professional services and legacy revenue, the company's strategic focus on AI and product integration suggests future growth potential. The Q&A section highlighted positive analyst sentiment, despite some evasive management responses. The stock is likely to see a positive movement, potentially boosted by the company's strong financial metrics and optimistic guidance.
HealthStream, Inc. (HSTM) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call reveals positive financial performance with growth in key products, increased net income, and improved cash balance. The transition to higher-margin SaaS and PaaS applications supports future margin growth. Despite a decline in gross margin, optimistic guidance and strategic moves, like AI integration and new product launches, indicate potential upside. The Q&A section highlights opportunities in monetization and market expansion, although some areas lack detailed projections. Overall, the sentiment leans positive due to strong financials and strategic initiatives, suggesting a potential stock price increase of 2% to 8%.
HealthStream, Inc. (HSTM) Q2 2025 Earnings Call Transcript
Unknown8-5
The earnings call shows a mix of positive and negative factors. Strong growth in core products and improved financial metrics are positive, but declines in legacy products and gross margin pressures are concerning. The Q&A section highlights uncertainties in gross margin recovery and pipeline building for new products. Despite revenue growth, the lack of precise guidance on key issues and the impact of healthcare employment cuts add uncertainty. Given these mixed signals, the stock price is likely to remain stable, leading to a neutral prediction.
HealthStream, Inc. (HSTM) Q1 2025 Earnings Call Transcript
Unknown5-7
The earnings call reflects several negative factors: delays in medium-sized deals, technology scaling issues, declining legacy product revenue, customer bankruptcy, and downward revenue guidance. Financial performance shows modest revenue growth but declines in operating income, net income, and EPS. While cash flows improved, the lack of a share repurchase program and minimal dividend increase add to concerns. The Q&A session highlighted management's vague responses on legacy product timelines and acquisition strategies, further adding to uncertainties. These factors collectively suggest a negative stock price movement over the next two weeks.
HSTM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
